Sign in

CIK 0001885827 · Non-accelerated filer<br>Emerging growth company

Virax Biolabs Group Ltd

Sign in to watch
Ticker
VRAX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Mar 31
Incorporated
Cayman Islands
Entity type
other
Phone
44 020 7788 7414
Business address
BIOCITY GLASGOW, BO'NESS ROAD, NEWHOUSE, LANARKSHIRE, United Kingdom, ML1 5UH
Former names
Virax Biolabs (Cayman) Ltd
  1. 424B3 Offering Prospectus
  2. 424B5 Offering Prospectus
  3. 424B3 Offering Prospectus
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. 424B5 Offering Prospectus
  6. 424B5 Offering Prospectus
  7. 424B5 Offering Prospectus
  8. 424B3 Offering Prospectus
  9. 424B3 Offering Prospectus
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. UPLOAD Other SEC-generated Letter
  12. 424B3 Offering Prospectus
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. UPLOAD Other SEC-generated Letter
  15. 424B3 Offering Prospectus
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. UPLOAD Other SEC-generated Letter
  18. 424B4 Offering Prospectus
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 1 of 2 · 33 filings